Zimmer Biomet Holdings Inc (ZBH)
109.83
+0.98
(+0.90%)
USD |
NYSE |
Nov 15, 09:53
Zimmer Biomet Holdings Free Cash Flow (Quarterly): 368.60M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 368.60M |
| June 30, 2024 | 192.20M |
| March 31, 2024 | 160.40M |
| December 31, 2023 | 537.60M |
| September 30, 2023 | 221.20M |
| June 30, 2023 | 198.30M |
| March 31, 2023 | 247.00M |
| December 31, 2022 | 180.80M |
| September 30, 2022 | 403.60M |
| June 30, 2022 | 311.60M |
| March 31, 2022 | 200.80M |
| December 31, 2021 | 308.10M |
| September 30, 2021 | 389.10M |
| June 30, 2021 | 429.30M |
| March 31, 2021 | 220.70M |
| December 31, 2020 | 403.00M |
| September 30, 2020 | 350.70M |
| June 30, 2020 | -71.80M |
| March 31, 2020 | 410.70M |
| December 31, 2019 | 371.50M |
| September 30, 2019 | 519.30M |
| June 30, 2019 | 44.50M |
| March 31, 2019 | 245.80M |
| December 31, 2018 | 332.00M |
| September 30, 2018 | 422.60M |
| Date | Value |
|---|---|
| June 30, 2018 | 366.30M |
| March 31, 2018 | 463.80M |
| December 31, 2017 | 356.70M |
| September 30, 2017 | 427.50M |
| June 30, 2017 | 409.80M |
| March 31, 2017 | 232.30M |
| December 31, 2016 | 572.60M |
| September 30, 2016 | 296.20M |
| June 30, 2016 | 333.50M |
| March 31, 2016 | 245.20M |
| December 31, 2015 | 413.40M |
| September 30, 2015 | 44.80M |
| June 30, 2015 | 166.80M |
| March 31, 2015 | 57.10M |
| December 31, 2014 | 312.70M |
| September 30, 2014 | 223.40M |
| June 30, 2014 | 222.10M |
| March 31, 2014 | 157.40M |
| December 31, 2013 | 277.40M |
| September 30, 2013 | 255.80M |
| June 30, 2013 | 167.30M |
| March 31, 2013 | 162.60M |
| December 31, 2012 | 324.70M |
| September 30, 2012 | 317.90M |
| June 30, 2012 | 206.70M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-71.80M
Minimum
Jun 2020
537.60M
Maximum
Dec 2023
291.67M
Average
309.85M
Median
Free Cash Flow (Quarterly) Benchmarks
| Stryker Corp | 1.304B |
| Boston Scientific Corp | 698.00M |
| NeuroOne Medical Technologies Corp | -2.375M |
| SINTX Technologies Inc | -2.574M |
| Nutriband Inc | -1.583M |